Study of Tolerant Kidney Transplant Recipients
NCT01338779 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 197
Last updated 2016-09-30
Summary
The purpose of this multi-center (observational) registry study is to establish a database of clinical and laboratory information that may help to identify any unique characteristics of tolerant participants that differ from participants who reject their kidney after discontinuing immunosuppressive drugs.
Conditions
- Transplant Rejection
- Kidney Transplantation
- Renal Transplantation
- Renal Transplant
- Transplant Tolerance
Sponsors & Collaborators
-
Immune Tolerance Network (ITN)
collaborator NETWORK -
National Institute of Allergy and Infectious Diseases (NIAID)
lead NIH
Principal Investigators
-
Kenneth Newell, MD, PhD · Emory University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-05-31
- Primary Completion
- 2015-08-31
- Completion
- 2015-08-31
Countries
- United States
Study Locations
More Related Trials
-
Regional Kidney Paired Donor Exchange in Sensitized Patients
NCT01896089 ·Status: UNKNOWN
-
Expanding the Scope of Post-transplant HLA-specific Antibody Detection and Monitoring in Renal Transplant Recipients
NCT06025240 ·Status: RECRUITING
-
Impact of Anti-HLA Donor-specific Antibodies in ABO-incompatible Kidney Transplantation
NCT03423901 ·Status: COMPLETED ·Phase: NA
-
Cytokine Kinetics Test to Assess the Presence or Absence of Tolerance in Organ Transplant
NCT00585858 ·Status: TERMINATED
-
Rejection Diagnosis in Kidney Transplants Patients
NCT03582436 ·Status: COMPLETED
-
Mechanistic Evaluation of Treatments for Acute Antibody-Mediated Rejection of the Kidney Transplant
NCT04496037 ·Status: NOT_YET_RECRUITING
-
TTV-based mAnagement Of Long-term ImmunosuppreSsion in Kidney Transplantation
NCT06829719 ·Status: RECRUITING ·Phase: NA
-
Immunosuppression's Long Term Impact on Anti-tumoral Oversight in Kidney Transplantation
NCT03227965 ·Status: COMPLETED ·Phase: NA
-
Donor Derived Cell-free DNA and Rejection of Kidney Allografts
NCT05995379 ·Status: COMPLETED
-
Immune Response in Desensitized Patients
NCT05785936 ·Status: UNKNOWN
-
Impact of Microvascular Inflammation on Kidney Allograft Outcome
NCT06496269 ·Status: COMPLETED
-
Proteogenomic Biomarker Panels in a Serial Blood & Urine Monitoring Study of Kidney Transplant Recipients
NCT01289717 ·Status: COMPLETED
-
Immunosuppressive Regimen on Changes in Renal Function and Transplant Rejection Rate in Patients With Lung Transplant
NCT03657004 ·Status: COMPLETED
-
New Urine and Blood Markers for Acute Kidney Injury in Liver Transplant Patients
NCT00855127 ·Status: WITHDRAWN
-
Noninvasive Methods to Monitor Graft Survival in Kidney Transplant Patients
NCT00308802 ·Status: COMPLETED
-
Tolerance Induction in Living Donor Kidney Transplantation With Hematopoietic Stem Cell Transplantation
NCT02199301 ·Status: UNKNOWN ·Phase: NA
-
Assessment of T-cell Response and In-vitro Proof-of-concept of T-cell Engineering in Chronic ESKD Patients.
NCT06474169 ·Status: RECRUITING
-
Dd-cfDNA and Treg in Prediction of Kidney Transplant Acute Rejection
NCT05084768 ·Status: RECRUITING
-
Anti-Angiotensin II Type 1 Receptor Antibodies and Kidney Transplant Outcomes
NCT03466775 ·Status: COMPLETED
-
Kidney Graft Tolerance KTOL
NCT06271343 ·Status: RECRUITING
-
Donor-specific Anti-HLA Antibodies Monitoring in Kidney Transplant Recipients
NCT03714113 ·Status: UNKNOWN ·Phase: NA
-
Urine CXCL10 Chemokine Monitoring Post-renal Transplant
NCT03140514 ·Status: COMPLETED ·Phase: NA
-
Measuring and Improving Medication Adherence in Kidney Transplant Patients
NCT02639949 ·Status: COMPLETED ·Phase: NA
-
Urine Testing to Detect Kidney Transplant Rejection
NCT00337220 ·Status: COMPLETED
-
Early Pharmacological and Immune Monitoring After Conversion to Belatacept in Renal Transplant Patients
NCT05632523 ·Status: COMPLETED